mirvetuximab
immunogen
['ovarian', 'immunogen ']
in a confirmatory phase 3 test of immunogen s elahere, the ovarian cancer drug handily beat chemotherapy with results that clinicians say could make the treatment the new standard of care for certain patients. the data were presented during the... 
Tracking what's next in medical innovation from hospitals, payers, medtech, pharma, digital & beyond. A @breakingmedia site.